Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8907)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 8, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang PC, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma. World J Hepatol 2016; 8(31): 1309-1317 [PMID: 27872682 DOI: 10.4254/wjh.v8.i31.1309] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i31/1309.htm |
| Number | Citing Articles |
| 1 |
Rie Matsushima-Nishiwaki, Noriko Yamada, Yuria Hattori, Yui Hosokawa, Junko Tachi, Takamitsu Hori, Osamu Kozawa, Salvatore V. Pizzo. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. PLOS ONE 2022; 17(1): e0262485 doi: 10.1371/journal.pone.0262485
|
| 2 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 3 |
Yuanwen Zheng, Peihua Nie, Shifeng Xu. Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR‐18a‐5p/NEDD9 axis. Journal of Cellular Biochemistry 2020; 121(5-6): 3135 doi: 10.1002/jcb.29581
|
| 4 |
Xuhua Xie, Xiaopei Xu, Changyu Sun, Zujiang Yu. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Experimental Cell Research 2019; 383(1): 111501 doi: 10.1016/j.yexcr.2019.111501
|
| 5 |
Vlad Alexandru Ionescu, Camelia Cristina Diaconu, Simona Bungau, Viorel Jinga, Gina Gheorghe. Current Approaches in the Allocation of Liver Transplantation. Journal of Personalized Medicine 2022; 12(10): 1661 doi: 10.3390/jpm12101661
|
| 6 |
Wei Zhang, Yanhui Wu, Bingwu Hou, Yadong Wang, Dongfeng Deng, Zhihao Fu, Zongquan Xu. A SOX9‐AS1/miR‐5590‐3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β‐catenin pathway. Molecular Oncology 2019; 13(10): 2194 doi: 10.1002/1878-0261.12560
|
| 7 |
Osman Nuri Dilek, Feyyaz Güngör, Arif Atay. Prophylactic Surgery. 2021; : 85 doi: 10.1007/978-3-030-66853-2_9
|
| 8 |
Mina Kim, Taegyu Kim, Hyun Young Lee, Sung Yeon Hong, Hee‐Jung Wang, Bong‐Wan Kim. Risk Factors for Beyond Milan Recurrence After Hepatic Resection for Single Hepatocellular Carcinoma No Larger Than 5 Centimeters. Liver Transplantation 2021; 27(8): 1116 doi: 10.1002/lt.26070
|
| 9 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
| 10 |
Ting Lei, Xiaodong Zhu, Kai Zhu, Fuxin Jia, Siqiao Li. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Cancer Biology & Therapy 2019; 20(7): 1007 doi: 10.1080/15384047.2019.1595276
|
| 11 |
Tong-tong He, Hong-wei Xiao, Maierhaba Wusiman, Dinuerguli Yishake, Ai-ping Fang, Yan Luo, Xiao-zhan Liu, Zhao-yan Liu, Hui-lian Zhu. Dietary intake of one-carbon metabolism-related nutrients and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort. Food & Function 2022; 13(15): 8081 doi: 10.1039/D2FO00943A
|
| 12 |
Chern-Horng Lee, Chien-Heng Shen, Cho-Li Yen, Tzung-Hai Yen, Sen-Yung Hsieh. Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy. Journal of Personalized Medicine 2023; 13(3): 397 doi: 10.3390/jpm13030397
|
| 13 |
Sung Whan Cha, Joon Hyung Sohn, Sung Hoon Kim, Yun Tae Kim, Seong Hee Kang, Mee‐Yon Cho, Moon Young Kim, Soon Koo Baik. Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2020; 35(4): 648 doi: 10.1111/jgh.14848
|
| 14 |
Ye-Bin Lu, Qin Jiang, Man-Yi Yang, Ji-Xiang Zhou, Qi Zhang. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis. Oncotarget 2017; 8(51): 88804 doi: 10.18632/oncotarget.21321
|
| 15 |
Jiye Fan, Jing Zhang, Shuhong Huang, Peng Li. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis. Biochemical and Biophysical Research Communications 2020; 521(1): 196 doi: 10.1016/j.bbrc.2019.10.105
|
| 16 |
Jianguo Yao, Xiaojian Liu. lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD. Aging 2023; 15(10): 4071 doi: 10.18632/aging.204566
|